A phase III trial (RTOG 0129) of two radiation-cisplatin regimens for head and neck carcinomas (HNC): Impact of radiation and cisplatin intensity on outcome.

被引：30
|
作者：
Ang, K.
Zhang, Q.
Wheeler, R. H.
Rosenthal, D. I.
Nguyen-Tan, F.
Kim, H.
Lu, C.
Axelrod, R. S.
Silverman, C. I.
Weber, R. S.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] RTOG Stat Ctr, Philadelphia, PA USA
[3] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[4] Ctr Hosp Univ Montreal, Montreal, PQ, Canada
[5] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA
[6] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[7] Univ Louisville, Louisville, KY 40292 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.5507
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5507
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Tirapazamine, cisplatin, and radiation versus fluorouracil, cisplatin, and radiation in patients with locally advanced head and neck cancer: A randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02)
    Rischin, D
    Peters, L
    Fisher, R
    Macann, A
    Denham, J
    Poulsen, M
    Jackson, M
    Kenny, L
    Penniment, M
    Corry, J
    Lamb, D
    McClure, B
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (01) : 79 - 87
  • [22] A phase II study of concomitant boost radiation plus concurrent weekly cisplatin for locally advanced unresectable head and neck carcinomas
    Contreras Martinez, J.
    Medina, J. A.
    Moreno, P.
    Villanueva, A.
    Rueda, A.
    Rico, J. M.
    Cobo, M.
    Sacchetti, A.
    Herruzo, I.
    RADIOTHERAPY AND ONCOLOGY, 2007, 82 : S44 - S45
  • [23] Long-Term Update of NRG/RTOG 0522: A Randomized Phase 3 Trial of Concurrent Radiation and Cisplatin With or Without Cetuximab in Locoregionally Advanced Head and Neck Cancer
    Caudell, Jimmy J.
    Torres-Saavedra, Pedro A.
    Rosenthal, David I.
    Axelrod, Rita S.
    Nguyen-Tan, Phuc Felix
    Sherman, Eric J.
    Weber, Randal S.
    Galvin, James M.
    El-Naggar, Adel K.
    Konski, Andre A.
    Echevarria, Michelle I.
    Dunlap, Neal E.
    Shenouda, George
    Singh, Anurag K.
    Beitler, Jonathan J.
    Garsa, Adam
    Bonner, James A.
    Garden, Adam S.
    Algan, Ozer
    Harris, Jonathan
    Le, Quynh-Thu
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 116 (03): : 533 - 543
  • [24] A Phase 2 Study of Bevacizumab With Cisplatin Plus Intensity-Modulated Radiation Therapy for Stage III/IVB Head and Neck Squamous Cell Cancer
    Fury, Matthew G.
    Lee, Nancy Y.
    Sherman, Eric
    Lisa, Donna
    Kelly, Katherine
    Lipson, Brynna
    Carlson, Diane
    Stambuk, Hilda
    Haque, Sofia
    Shen, Ronglai
    Kraus, Dennis
    Shah, Jatin
    Pfister, David G.
    CANCER, 2012, 118 (20) : 5008 - 5014
  • [25] A phase III randomized trial of two cisplatin-based concurrent chemoradiation (CCRT) regimens for locally advanced head and neck squamous cell carcinoma (LAHNSCC)
    Rodriguez, Cristina P.
    Adelstein, David J.
    Rybicki, Lisa A.
    Savvides, Panayiotis
    Saxton, Jerrold P.
    Koyfman, Shlomo A.
    Greskovich, John
    Yao, Min
    Scharpf, Joseph
    Lavertu, Pierre
    Wood, Benjamin J.
    Burkey, Brian
    Lorenz, Robert
    Rezaee, Rod
    Zender, Chad
    Ives, Denise I.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [26] Phase II trial of neoadjuvant docetaxel (T), cisplatin (P), and cetuximab (E) followed by concurrent radiation (X), P, and E in locally advanced head and neck cancer (HNC)
    Argiris, A. E.
    Gibson, M. K.
    Heron, D. E.
    Smith, R. P.
    Ferris, R. L.
    Lai, S. Y.
    Kim, S. W.
    Branstetter, B. F.
    Johnson, J. T.
    Grandis, J. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [27] Phase II trial of bevacizumab plus cetuximab plus cisplatin with concurrent intensity-modulated radiation therapy for patients with stage III/IVB head and neck squamous cell carcinoma
    Fury, Matthew G.
    Xiao, Han
    Sherman, Eric J.
    Baxi, Shrujal
    Smith-Marrone, Stephanie
    Schupak, Karen
    Gewanter, Richard
    Gelblum, Daphna
    Haque, Sofia
    Schoder, Heiko
    Shah, Jatin P.
    Katabi, Nora
    Kurtzman, Rachel
    Lipson, Brynna
    Cox, Lisa
    Lee, Nancy Y.
    Pfister, David G.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 : E566 - E570
  • [28] Weekly Cisplatin Plus Radiation for Postoperative Head and Neck Cancer (JCOG1008): A Multicenter, Noninferiority, Phase II/III Randomized Controlled Trial
    Kiyota, Naomi
    Tahara, Makoto
    Mizusawa, Junki
    Kodaira, Takeshi
    Fujii, Hirofumi
    Yamazaki, Tomoko
    Mitani, Hiroki
    Iwae, Shigemichi
    Fujimoto, Yasushi
    Onozawa, Yusuke
    Hanai, Nobuhiro
    Ogawa, Takenori
    Hara, Hiroki
    Monden, Nobuya
    Shimura, Eiji
    Minami, Shujiro
    Fujii, Takashi
    Tanaka, Kaoru
    Homma, Akihiro
    Yoshimoto, Seiichi
    Oridate, Nobuhiko
    Omori, Koichi
    Ueda, Tsutomu
    Okami, Kenji
    Ota, Ichiro
    Shiga, Kiyoto
    Sugasawa, Masashi
    Asakage, Takahiro
    Saito, Yuki
    Murono, Shigeyuki
    Nishimura, Yasumasa
    Nakamura, Kenichi
    Hayashi, Ryuichi
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (18) : 1980 - +
  • [29] A Phase 1 Study of Everolimus plus Weekly Cisplatin plus Intensity Modulated Radiation Therapy in Head-and-Neck Cancer
    Fury, Matthew G.
    Lee, Nancy Y.
    Sherman, Eric
    Ho, Alan L.
    Rao, Shyam
    Heguy, Adriana
    Shen, Ronglai
    Korte, Susan
    Lisa, Donna
    Ganly, Ian
    Patel, Snehal
    Wong, Richard J.
    Shaha, Ashok
    Shah, Jatin
    Haque, Sofia
    Katabi, Nora
    Pfister, David G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (03): : 479 - 486
  • [30] Long-term results of Intergroup RTOG 91-11: A phase III trial to preserve the larynx - Induction cisplatin/5-FU and radiation therapy versus concurrent cisplatin and radiation therapy versus radiation therapy.
    Forastiere, A. A.
    Maor, M.
    Weber, R. S.
    Pajak, T.
    Glisson, B.
    Trotti, A.
    Ridge, J.
    Ensley, J.
    Chao, C.
    Cooper, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 284S - 284S
12345